Table 2 Univariate analysis of prognostic factors involved in survival.
From: PD-L1 predicts poor prognosis for nasopharyngeal carcinoma irrespective of PD-1 and EBV-DNA load
Ā | Cases (nā=ā99) | PFS | OS | |||
---|---|---|---|---|---|---|
Variables | X 2 | P value 1 | X 2 | P value 1 | ||
Gender | Male | 68 | 0.725 | 0.394 | 0.344 | 0.558 |
Female | 31 | Ā | Ā | Ā | Ā | |
Age (years) | <50 | 60 | 2.327 | 0.127 | 5.551 | 0.018* |
ā„50 | 39 | Ā | Ā | Ā | Ā | |
Tumour size | rT1-3 | 71 | 5.030 | 0.025 * | 6.959 | 0.008 ** |
rT4 | 28 | Ā | Ā | Ā | Ā | |
Nodal status | N0-1 | 54 | 2.227 | 0.136 | 0.005 | 0.941 |
N2-3 | 45 | Ā | Ā | Ā | Ā | |
Clinical stage3 | I-III | 65 | 2.306 | 0.129 | 4.372 | 0.037 * |
IV | 34 | Ā | Ā | Ā | Ā | |
GTVnx (mm3)2 | <29.6 | 45 | 5.049 | 0.025 * | 8.090 | 0.004 ** |
ā„29.6 | 54 | Ā | Ā | Ā | Ā | |
EBV-DNA load | undetectable | 22 | 0.324 | 0.569 | 0.005 | 0.942 |
detectable | 77 | Ā | Ā | Ā | Ā | |
Treatment | IMRT | 10 | 2.273 | 0.132 | 1.020 | 0.312 |
IMRT+CT | 89 | Ā | Ā | Ā | Ā | |
PD-1 positivity | negative | 55 | 0.251 | 0.616 | 0.334 | 0.563 |
positive | 44 | Ā | Ā | Ā | Ā | |
PD-L1 H-score2 | <155 | 38 | 2.327 | 0.127 | 5.870 | 0.015 * |
ā„155 | 61 | Ā | Ā | Ā | Ā |